CN101633691B - Hydrogen production associated protein, coding genes thereof and application thereof - Google Patents
Hydrogen production associated protein, coding genes thereof and application thereof Download PDFInfo
- Publication number
- CN101633691B CN101633691B CN2008101169755A CN200810116975A CN101633691B CN 101633691 B CN101633691 B CN 101633691B CN 2008101169755 A CN2008101169755 A CN 2008101169755A CN 200810116975 A CN200810116975 A CN 200810116975A CN 101633691 B CN101633691 B CN 101633691B
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- sequence
- engineering bacteria
- hydrogen production
- ldhd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000001257 hydrogen Substances 0.000 title claims abstract description 120
- 229910052739 hydrogen Inorganic materials 0.000 title claims abstract description 120
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title claims abstract description 111
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 54
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title abstract description 43
- 241000894006 Bacteria Species 0.000 claims abstract description 76
- 241000588915 Klebsiella aerogenes Species 0.000 claims abstract description 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 8
- 235000018102 proteins Nutrition 0.000 claims description 12
- 206010010144 Completed suicide Diseases 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 8
- 230000009849 deactivation Effects 0.000 claims description 7
- 239000005547 deoxyribonucleotide Substances 0.000 claims description 4
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims description 4
- 230000006801 homologous recombination Effects 0.000 claims description 4
- 238000002744 homologous recombination Methods 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 230000008521 reorganization Effects 0.000 claims description 4
- 230000009261 transgenic effect Effects 0.000 claims description 4
- 230000008676 import Effects 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 239000000758 substrate Substances 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 7
- 125000000539 amino acid group Chemical group 0.000 abstract description 5
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 239000000047 product Substances 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 22
- 238000000034 method Methods 0.000 description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 16
- 230000008569 process Effects 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 235000019253 formic acid Nutrition 0.000 description 8
- 150000002431 hydrogen Chemical class 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000012807 shake-flask culturing Methods 0.000 description 5
- 241000193403 Clostridium Species 0.000 description 4
- 241000605909 Fusobacterium Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 241001112695 Clostridiales Species 0.000 description 3
- 108010001539 D-lactate dehydrogenase Proteins 0.000 description 3
- 241000588914 Enterobacter Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940049547 paraxin Drugs 0.000 description 3
- 230000000243 photosynthetic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 108010020056 Hydrogenase Proteins 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 108010072136 iron hydrogenase Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001494908 Akihito Species 0.000 description 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000703924 Enterobacter cloacae IIT-BT 08 Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 229910003271 Ni-Fe Inorganic materials 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 235000007260 kalia Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 102220004457 rs11567847 Human genes 0.000 description 1
- 102220023257 rs387907546 Human genes 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a hydrogen production associated protein, coding genes thereof and application thereof. The hydrogen production associated protein is a protein (a) and a protein (b), wherein the protein (a) has an amino acid sequence represented by the No.1 sequence 1 in a sequence table; and the protein (b) has an amino acid sequence that has substituents of one or more amino acid residues, lacks one or more amino acid residues or has one or more additional amino acid residues and is associated with the hydrogen production and derived from the sequence 1. The hydrogen production associated protein provided by the invention is named as LdhD, and a strain of engineering bacteria is obtained by inactivating the coding genes ldhd of the protein in the E.aerogenes IAM1183. The engineering bacteria have the advantages of strong environmental adaptability, wide substrate range, strong substrate using ability, high hydrogen producing efficiency, and the suitability for biological hydrogen production and have great instruction significance for hydrogen production by the E.aerogenes.
Description
Technical field
The present invention relates to a kind of hydrogen production associated protein and encoding gene thereof and application.
Background technology
Nowadays the fossil energy system of having set up since the world industry revolution of 18th century is being faced with two challenges greatly: 1) the fossil energy reserves reduce day by day, are faced with exhausted danger; 2) burning of fossil oil has produced a large amount of pollution substances, particularly CO
2The Greenhouse effect that the isothermal chamber gas purging causes, the environment of depending on for existence to the mankind brings huge threat.Therefore, the renewable and clean energy resource of Sustainable Development, progressively substituting fossil energy is the grand strategy problem that concerns national energy security, environmental safety and social stability peaceful development.
Hydrogen Energy is as substituting one of clean energy the future that has potentiality, is energy carrier efficiently, has energy density height, cleaning, renewable, products of combustion and be water and characteristics such as pollution-free, is very good renewable energy source.At present, hydrogen mainly transforms (account for hydrogen source 96%) and water electrolysis hydrogen production (accounting for 4%) from the reformation of fossil oil, fails to break away from the dependence to original fossil energy.Therefore, how to utilize renewable resources to obtain the concern widely that hydrogen is subjected to people constantly.Biological hydrogen production is one of important channel that addresses this problem.Biological hydrogen production have normal temperature and pressure reaction, mild condition, environmentally friendly, can utilize discarded biological substance to be advantages such as substrate, can be with environmental pollution improvement, reduce disposal of pollutants and interrelate, be very good hydrogen production process.
The research of modern biological hydrogen production starts from the energy dilemma of the seventies in 20th century, and since the nineties, along with the further understanding of people to Greenhouse effect, biological hydrogen production has caused people's extensive attention more as the hydrogen production process of Sustainable development.Bio-hydrogen production technology comprises optical drive process and two kinds of routes of anaerobically fermenting.The former utilizes photosynthetic bacterium or algae directly conversion of solar energy to be hydrogen, is a very ideal process, but because the light utilising efficiency is very low, factors such as photoreactor difficult design are difficult to push to use at no distant date.What the latter adopted is the hydrogenogens anaerobically fermenting, and its advantage is that product hydrogen speed is fast, reactor design simple and can combines with discarded biological utilization, with respect to the former the easier industrial application that realizes in the near future.
Fermentation method hydrogen manufacturing starts from middle nineteen sixties, and the nineties comes into one's own, but progress and little.Late nineteen nineties is to the beginning of this century, and people recognize that ferment for hydrogen production is easier and realize industrialization in the near future, have increased the scientific research input of dark ferment for hydrogen production aspect greatly, have produced the basic research result of a collection of relevant culture process.The research of the hydrogen production process that combines with the abandoned biomass processing in recent years greatly increases, some of them have reached the pilot scale level, but mainly concentrate on reactor type design, the technical study, and the mixed culture hydrogen generation efficiency is lower than pure culture, total transformation efficiency is not high, and this is the bottleneck place of ferment for hydrogen production just also.Solving the key of ferment for hydrogen production bottleneck, is to realize technological breakthrough, improves the hydrogen yield.Studies show that, only, can't fundamentally break through the low problem of hydrogen generation efficiency, must pay attention to the research and development of highly effective hydrogen yield bacterial classification from the angle of technology.
For many years, the hydrogenogens kind of using in the dark ferment for hydrogen production mainly comprises enterobacter (Enterobacter), fusobacterium (Clostridium), Escherichia (Escherichia) and bacillus (Bacillus), and is wherein maximum with the correlative study of enterobacter and fusobacterium especially.Fusobacterium produces the hydrogen rate and can reach 2.36mol/mol glucose, enteroaerogen belongs to product hydrogen rate and reaches as high as 3mol/mol glucose (being 6mol/mol sucrose) [Kumar, N.and Das, D.Bioprocess Engineering 23,205-208 (2000)], [Kumar, N.andDas, D.Process Biochemistry 35,589-593 (2000)].With clostridium (Clostridium sp) is that the mechanism of the obligatory anaerobic bacteria fermentation and hydrogen production of representative is: generate pyruvic acid after the glucose glycolysis, in forming the acetic acid process, a part of electronics forms hydrogen by ferredoxin under the effect of hydrogen enzyme.One mole glucose can form 4 mol of hydrogen and 2 molecule acetic acid.Therefore, in the time of the obligatory anaerobic bacteria fermentation and hydrogen production, must follow organic acid formation such as acetic acid.Amphimicrobian hydrogenogens E.aerogenes separates approach by sugar and tricarboxylic acid cycle (TCA) approach produces NADH and ATP, the hydrogen enzyme is converted to hydrogen by NADH with proton, producing hydrogen theoretical transformation rate is that 1 mole of glucose forms 12mol hydrogen, is far longer than the hydrogen yield of obligatory anaerobic bacteria.Therefore, E.aerogenes is the important bacterial classification of the efficient ferment for hydrogen production technology of exploitation.
Along with the develop rapidly of biotechnology, the simple bacterial screening and the optimization of culture process can not have been satisfied the demand that improves hydrogen generation efficiency.The research of ferment for hydrogen production need enter cell interior, by the transformation of hydrogen enzyme and metabolism network thereof being strengthened the hydrogen process of producing.On gene pool, can obtain at present to surpass gene order [the Paulette M.Vignais of 100 kinds of hydrogen enzymes, Bernard Billoud, Jacques Meyer.FEMS MicrobiologyReviews 25,455-501 (2001)], but still have the hydrogenase gene of a large amount of known hydrogenogens strains not cloned as yet, seeking more hydrogenase gene is the important directions [Kalia of biological hydrogen production research, V.C., Lal, S., Ghai, R., Mandal, M.and Chauhan, A.Trends in Biotechnology 21,152-156 (2003)].Different hydrogen enzymes have different functions, compare with other enzyme system, and people are also very limited to the understanding of hydrogen enzyme.
At present, the more clearly of research is the gene of colibacillary hydrogen enzyme I, II, III and IV, and they all belong to Ni-Fe hydrogen enzyme, relevant with product hydrogen [Andrews, S.C., Berks of hydrogen enzyme III wherein with IV, B.C., Mcclay, J., Ambler, A., Quail, M.A., Golby, P.and Guest, J.R.Microbiology143,3633-3647 (1997)], and I, II are relevant with suction hydrogen process.The hydrogen enzyme of fusobacterium all belongs to iron hydrogen enzyme, and three clostridial iron hydrogen enzymes have sequencing result, but not clear about its subsidiary gene, regulatory mechanism.Be cloned into clostridial iron hydrogenase gene, and in photosynthetic bacterium, obtained heterogenous expression, strengthened the product hydrogen process of photosynthetic bacteria.The expression of clostridial iron hydrogenase gene in intestinal bacteria be not success but, may be since clostridium and intestinal bacteria for [the Yasuo Asada that causes inequality of the subsidiary gene system of iron hydrogen expression of enzymes, Yoji Koike, JorgSchnackenberg, Masato Miyake, Ieaki Uemura, Jun Miyake.Biochimica etBiophysica Acta 1490,269-278 (2000)].Recently, the method by iron hydrogen enzyme conserved sequence design such as Mishra J. clones the iron hydrogen enzyme about 450bp from E.cloacae IIT-BT08, and in the intestinal bacteria that do not produce hydrogen heterogenous expression, verified its function, the result shows that this hydrogen enzyme is positioned at tenuigenin [Mishra, J., Kumar, N., Ghosh, A.K.and Das, D.International Journal of Hydrogen Energy27,1475-1479 (2002)], [Mishra, J., Khurana, S., Kumar, N., Ghosh, A.K.andDas, D.Biochemical and Biophysical Research Communications 324,679-685 (2004)].The early-stage Study of enteroaerogen E.aerogenes shows, on its cytolemma, the NADH effect that produces in hydrogen enzyme and the cell generates hydrogen [Nakashimada, Y., Rachman, M.A., Kakizono, T.andNishio, N.International Journal of Hydrogen Energy 27,1399-1405 (2002)].Therefore study hydrogen enzyme characteristic, gene and the biological function explore thereof of this Pseudomonas, significant for the technological breakthrough that realizes raising enteroaerogen product hydrogen yield.
Studies show that to what intestinal bacteria produced the hydrogen process intestinal bacteria can directly utilize formic acid, also the formic acid that can produce in assimilation glucide metabolic process is substrate, and under the effect of formic acid lyase system, decompose formic acid generates CO
2And H
2[Akihito?Yoshida,Taku?Nishimura,Hideo?Kawaguchi,1?Masayuki?Inui,andHideaki?Yukawa*.Appl?Environ?Microbiol.71:6762-6768(2005)]。It is to produce the fastest approach of hydrogen that formic acid produces the hydrogen approach.
Enteroaerogen is a facultative anaerobe, and fast growth under anaerobic can produce hydrogen, and advantage such as it is wide to have the substrate of utilization scope, and growth adaptability is strong, is the bacterial strain with good industrial proterties.Existing many reports about enteroaerogen product hydrogen, but be mostly aspect technology and cultivation [E.Palazzi, B.Fabiano, P.Perego.Bioproeess Eng.22:205-213 (2000) .], the relevant relevant gene of hydrogen that produces is also without any report.Studies show that, enteroaerogen has the utilize formic acid similar with intestinal bacteria and produces the ability [Tatsuo of hydrogen, K., Shigeharu, T.Mar Biotechnol.7:112-118 (2005) .], and it has the hydrogen of suction process, [the Y.L Ren. that exists that inhales the hydrogen enzyme is promptly arranged, X.H.Xing., C.Zhang., and Z.X.Gou.Biotechnol Lett.27 (14): 1029-1033 (2005) .].Metabolic analysis shows, with glucose be substrate when carrying out ferment for hydrogen production, in its metabolic end product, concentration of lactic acid is near 70%, this also is that to cause in the fermenting process that medium pH descends too fast, thus when suppressing thalli growth and having reduced fermentation to the major cause of the more effective utilization of substrate.
Summary of the invention
The purpose of this invention is to provide a kind of hydrogen production associated protein and encoding gene thereof and application.
Hydrogen production associated protein provided by the invention, name is called LdhD, derives from enteroaerogen E.aerogenesIAM1183, is following (a) or protein (b):
(a) protein of forming by the aminoacid sequence shown in the sequence in the sequence table 1;
(b) with the aminoacid sequence of sequence 1 through the replacement of one or several amino-acid residue and/or disappearance and/or interpolation and with produce hydrogen relevant by sequence 1 deutero-protein.
In order to make the albumen in (a) be convenient to purifying, proteinic N-terminal or C-terminal that can the aminoacid sequence shown in the sequence 1 is formed in by sequence table connect label as shown in table 1.
The sequence of table 1 label
Label | Residue | Sequence |
Poly-Arg | 5-6 (being generally 5) | RRRRR |
Poly-His | 2-10 (being generally 6) | |
FLAG | ||
8 | DYKDDDDK | |
Strep-tag?II | 8 | WSHPQFEK |
c- |
10 | EQKLISEEDL |
Above-mentioned (b) but in the albumen synthetic, also can synthesize its encoding gene earlier, carry out biology again and express and to obtain.Proteic encoding gene in above-mentioned (b) can be by the codon with one or several amino-acid residue of disappearance in the dna sequence dna shown in the sequence in the sequence table 2, and/or carry out the missense mutation of one or several base pair, and/or obtain at the encoding sequence that its 5 ' end and/or 3 ' end connects the label shown in the table 1.
Described proteic encoding gene (ldhd) also belongs to protection scope of the present invention.
Described proteic encoding gene specifically can be following 1) or 2) or 3) dna molecular:
1) its encoding sequence is the dna molecular shown in the sequence 2 in the sequence table;
2) under stringent condition with 1) the dna sequence dna hybridization that limits and the dna molecular of encoding said proteins;
3) with 1) or 2) dna sequence dna that limits has 90% above homology, and the identical function protein DNA molecule of encoding.
Above-mentioned stringent condition can be at 6 * SSC, in the solution of 0.5%SDS, 65 ℃ of hybridization down, uses 2 * SSC then, and 0.1%SDS and 1 * SSC, 0.1%SDS respectively wash film once.
The expression cassette, recombinant expression vector, transgenic cell line or the reorganization bacterium that contain described proteic encoding gene all belong to protection scope of the present invention.
The present invention also protects a hydrogen-producing engineering bacteria, is that the ldhd gene obtains described in the deactivation E.aerogenes IAM1183.
Described deactivation realizes by homologous recombination, specifically is to change realization by this affine single cross of parents.
Described homologous recombination specifically can import E.aerogenes IAM1183 with suicide carrier pGP704-ldhd and realize; Described suicide carrier pGP704-ldhd be in the multiple clone site insertion sequence table of pGP704 sequence 2 from 5 ' terminal the 363rd to 898 recombinant vectors that deoxyribonucleotide obtains.
The present invention also protects suicide carrier pGP704-ldhd, be in the multiple clone site insertion sequence table of pGP704 sequence 2 from 5 ' terminal the 363rd to 898 recombinant vectors that deoxyribonucleotide obtains.
The transgenic cell line or the reorganization bacterium that contain described suicide carrier pGP704-ldhd all belong to protection scope of the present invention.
Described engineering bacteria can be applicable to biological hydrogen production.
The present invention is a starting strain with the enteroaerogen (E.aerogenes) with highly effective hydrogen yield potentiality, by the ldhd gene in the enteroaerogen (E.aerogenes) is carried out deactivation, obtain a strain hydrogen production potential and improved, utilized the strong engineering bacteria of glucose ability, can be applicable to biological hydrogen production, to utilizing enteroaerogen hydrogen manufacturing, has huge directive significance.
The engineering bacteria that the present invention obtains has the following advantages:
1) starting strain E.aerogenes IAM1183 is a facultative anaerobe, all can grow fast under aerobic, anaerobic condition, and is strong to environmental compatibility; Utilize its carry out biological hydrogen production have the substrate of utilization scope wide, utilize the substrate ability strong and produce the hydrogen advantage of higher, be to have the potential strain excellent that is applied to industrial biological hydrogen preparing.
2) engineering bacteria that obtains of the present invention is except having original bacterium 1) advantage, it is stronger also to have the substrate utilization ability, the characteristics that hydrogen production potential further improves.
Following embodiment is convenient to understand better the present invention, but does not limit the present invention.
Description of drawings
Fig. 1 is the PCR electrophorogram of ldhd gene
Fig. 2 is that the PCR of suicide vector pGP704-ldhd identifies figure
Fig. 3 is monoclonal antibody and the two anti-screening figure of engineering bacteria E.aerogenes IAM1183-Δ ldhd
Fig. 4 is that the PCR of engineering bacteria E.aerogenes IAM1183-Δ ldhd identifies figure
Fig. 5 is the growth curve of engineering bacteria E.aerogenes IAM1183-Δ ldhd
Fig. 6 is the pH change curve in the engineering bacteria E.aerogenes IAM1183-Δ ldhd process of growth
Fig. 7 is the product hydrogen situation of engineering bacteria E.aerogenes IAM1183-Δ ldhd
Embodiment
Experimental technique among the following embodiment if no special instructions, is ordinary method.
Used primer is as follows among the present invention:
Ldh-fw:ATGAAAATCGCSGTTTATAG;
Ldh-rw:TTAGACGATGGCGTTCGGAC;
Ldh-E-fw:cg
GAATTCCCGCGCTTACCAGCGTACC;
Ldh-E-rw:cg
GAATTCGTCAGGAAAGCCTGATGCCC;
Primer-Pgp-1-fw:CATGCGCTCCATCAAGAAGA;
Primer-Pgp-2-rw:GTGGGTCTCGCGGTATCATT。
Culture medium prescription and purposes related in following examples are as follows:
(1) LB substratum (L
-1): peptone 10g, yeast soak powder 5g, NaCl 10g, agar powder 15g (adding during solid medium); Be used for bacterial classification short term storage and activation culture.
(2) dextrose culture-medium (L
-1): glucose 15g, peptone 5g, K
2HPO
43H
2O 14g, KH
2PO
46g, (NH
4)
2SO
42g, MgSO
47H
2O 0.2g; Be used for ferment for hydrogen production.
The acquisition of embodiment 1, enteroaerogen ldhd gene
According to the D-serum lactic dehydrogenase of having delivered (D-lactate dehydrogenase) gene order, design a pair of degenerate primer Ldh-fw and Ldh-rw.Genomic dna with enteroaerogen (E.aerogenes IAM1183) (available from using microbe institute of Tokyo Univ Japan (IAM) strain library) is that template is carried out pcr amplification.
The PCR product is carried out agarose gel electrophoresis detect, electrophorogram is seen Fig. 1.Among Fig. 1, the 1:PCR product; 2:Marker.
The result shows, obtained the band that molecular weight is about 900bp.With 4 ℃ of preservations of this PCR product, serve extra large Invitrogen Corporation order-checking, sequencing result shows that the nucleotide sequence that increases is seen the sequence 2 of sequence table, encoding amino acid sequence is the protein of the sequence 1 of sequence table.
Through online comparison, the D-lactatedehydrogenase gene of sequence 2 and Klebsiella pneumoniae subsp has 84% highest homology, and the D-lactate dehydrogenase albumen of sequence 1 and Klebsiella oxytoca and Klebsiella pneumoniae subsp has highest homology.With the DNA called after ldhd gene of nucleotide sequence shown in sequence 2, with the protein called after LdhD albumen of aminoacid sequence shown in sequence 1.
The acquisition of embodiment 2, enteroaerogen E.aerogenes IAM1183-Δ ldhd
One, the structure of suicide vector pGP704-ldhd
Design a pair of primer Ldh-E-fw, the Ldh-E-rw that has EcoR I restriction enzyme site.Genomic dna with enteroaerogen (E.aerogenes IAM1183) is that template is carried out pcr amplification, obtains the fragment of bp more than 540.The EcoRI enzyme is cut the PCR product, with the pGP704[Kolter that EcoR I enzyme is cut, R.Inuzuka, M.and Helinski, D. (1978) .Cell 15:1199-1208, Miller, V.and Mekalanos, J. (1988) .J.Bact.170:2575-2583] connect.Connect product Transformed E .coli DH5 α (the precious biotech firm in Dalian), in the screening of LB paraxin (24mg/mL) resistant panel, the transformant that picking is correct extracts plasmid and carries out the PCR evaluation, and is specific as follows:
According to a pair of primer Primer-Pgp-1-fw of the sequences Design on the pGP704 and Primer-Pgp-2-rw.With primer Ldh-E-fw and Primer-Pgp-2-rw recombinant plasmid is carried out PCR and identify, see the swimming lane 1 of Fig. 2.Equally, with primer Primer-Pgp-1-fw and Ldh-E-rw recombinant plasmid is carried out PCR and identify, see the swimming lane 2 of Fig. 2.Among Fig. 2, swimming lane 3 is the pGP704 plasmid, and swimming lane 4 is Marker.The result shows, has obtained the recombinant plasmid of expection, with its called after pGP704-ldhd suicide vector.
Two, the acquisition of enteroaerogen E.aerogenes IAM1183-Δ ldhd
1, with the pGP704-ldhD suicide vector, the mode by electricity transforms imports original bacterium E.aerogenesIAM1183.
2, the E.aerogenes IAM1183 after will transforming, 37 ℃ of rejuvenation 45 minutes are coated on the enterprising row filter of LB solid plate that contains paraxin (24mg/mL).
3, picking is containing the bacterium colony of growing on the chlorampenicol resistant flat board, is transferred on the two resistance LB flat boards that contain penbritin (100mg/mL) and paraxin (24mg/mL), cultivates 12h.The bacterium colony that to grow on two resistant panel, picking is to new two resistance LB flat boards.
Monoclonal antibody screening and two anti-results of screening are seen Fig. 3.Among Fig. 3, left side figure is two anti-results of screening, and right figure is the monoclonal antibody results of screening.Observe the well-grown of finding 2# bacterium and 5# bacterium.
Extract the genomic dna of 2# bacterium and 5#, use primer Ldh-E-fw and Primer-Pgp-2-rw (A) respectively; Primer-Pgp-2-fw and Ldh-E-rw (B); Ldh-E-fw and Ldh-E-rw (C) carry out PCR as primer to the DNA of 2# and 5# and identify that the result as shown in Figure 4.Among Fig. 4, the 1:2# transformant carries out the product of PCR with primer A; The 2:2# transformant carries out the product of PCR with primer B; The 3:2# transformant carries out the product of PCR with primer C; The 4:5# transformant carries out the product of PCR with primer A; The 5:5# transformant carries out the product of PCR with primer B; The 6:5# transformant carries out the product of PCR with primer C.
The result shows: the 2# transformant is consistent with expected result, is correct transformant; The 5# transformant does not obtain the characteristic strip of expecting, is the false positive thalline.With 2# bacterium called after engineering bacteria E.aerogenes IAM1183-Δ ldhd.
The growth characteristics of embodiment 3, engineering bacteria, product hydrogen performance and metabolism stream
One, the growth characteristics of engineering bacteria, product hydrogen performance and metabolism stream under the shake-flask culture condition
Respectively engineering bacteria E.aerogenes IAM1183-Δ ldhd and wild bacterium E.aerogenes IAM1183 are carried out shake-flask culture, detect their growth characteristics, product hydrogen performance and metabolism stream, concrete steps are as follows:
Dress 20mL dextrose culture-medium inserts substratum with the engineering bacteria after the activation in the 70mL serum bottle, carries out shake-flask culture; Wild bacterium after will activating simultaneously carries out the shake-flask culture of similarity condition, in contrast.
(1) seed culture: activatory engineering bacteria (or wild bacterium) is seeded to the 15ml centrifuge tube that contains 5ml LB substratum, and 37 ℃, 170rpm, airbath overnight incubation obtain kind of a daughter bacteria.
(2) anaerobism shake-flask culture: will plant daughter bacteria and be seeded to the 70ml serum bottle (using the air in nitrogen replacement culturing bottle top and the substratum in advance) that contains the 20ml dextrose culture-medium, inoculum size is 2.5% (v/v).37 ℃, 170rpm, airbath were cultivated 24 hours.
Utilize spectrophotometer (UV-1206, SHIMADZU company (Japan)) to measure the growing state of thalline; Utilize pH meter (CHN060 (828), ORION company (U.S.)) to measure the changing conditions of pH.Cultivate and after 16 hours meta-bolites is detected.Behind fermented product centrifuging and taking supernatant, filter.Utilize the output and the composition of high-pressure liquid chromatography metabolite.High-pressure liquid phase gas spectrum is (HPLC-10A, SHIMADZU company (Japan).Three repetitions are established in test, and all results are multiple mean value three times, represent with mean+SD.
The OD of engineering bacteria and wild bacterium
600Variation see Fig. 5, the pH of the nutrient solution of engineering bacteria and wild bacterium changes and sees Fig. 6.The product hydrogen situation of engineering bacteria and wild bacterium changes sees Fig. 7; The metabolic flux analysis of engineering bacteria the results are shown in Table 2.
The metabolic flux analysis (n=3) of table 2E.aerogenes IAM1183-Δ ldhd engineering bacteria
The result shows: the 1) OD of engineering bacteria
600Obviously improve.2) the pH value lowering speed of engineering bacteria is less than wild bacterium, and when pH=5.5, no longer descends.3) utilization ratio of engineering bacteria glucose reaches 100%, is higher than the utilization ratio 57.7% of wild bacterium, illustrates that the deactivation of Δ ldhd can effectively increase the flux that produces the hydrogen pathways metabolism, produces the hydrogen yield thereby improve cell.3) growing amount of engineering bacteria lactic acid is much smaller than wild bacterium.5) 2 of engineering bacteria, 3-butyleneglycol, succsinic acid and alcoholic acid yield all increase to some extent than wild bacterium, and above-mentioned substance all is to rely on NADH in the born of the same parents and the meta-bolites that produces, demonstrate the increase of available reducing power in the born of the same parents, and this is an essential condition that helps producing hydrogen.6) acetate of engineering bacteria and ethanol production sum have the raising of certain amplitude than wild type strain, show that formic acid produces the hydrogen approach and is reinforced in producing the hydrogen process, have reached the effect of the product hydrogen of expection.
Two, jar fermentation
For hydrogen production potential and the substrate utilization ability and the metabolism flow direction that detects engineering bacteria E.aerogenes IAM1183-Δ ldhd, carry out following operation:
The E.aerogenes IAM1183-Δ ldhd engineering bacteria that activation is good is inoculated in the LB substratum of 30mL, and incubated overnight obtains seed liquor.The 60mL seed liquor is inoculated in the 5L fermentor tank that contains the 3L dextrose culture-medium, and 37 ℃ are carried out anaerobically fermenting.Detect amounts of hydrogen and the meta-bolites produced, the same step 1 of method.The operation of wild bacterium is the same, in contrast.The results are shown in Table 3.
The hydrogen output and the metabolic flux analysis of table 3 E.aerogenes IAM1183-Δ ldhd engineering bacteria
The result shows: 1) output of engineering bacteria hydrogen is 1.9 times of wild bacterium.2) growing state of engineering bacteria is better than original bacterium, whole OD
600Be 1.5 times of original bacterium.3) engineering bacteria pH lowering speed is much smaller than wild bacterium, and when dropping to 5.5, then no longer descends, and along with the prolongation of incubation time, pH value is slightly gone up, and illustrates that the organic acid of generation is partially consumed.4) utilization ratio of engineering bacteria glucose can reach 98.9%, much larger than 85.8% of wild bacterium.5) growing amount of engineering bacteria lactic acid is far smaller than wild bacterium.6) engineering bacteria succsinic acid, formic acid, acetate, 2,3-butyleneglycol, alcoholic acid output are greater than wild bacterium.
Test shows, the deactivation meeting of target gene is caused the variation of corresponding enzymic activity in the born of the same parents, and then changes metabolic flux, increases the output of target product.The biological character that hydrogen is produced in the fermentation of engineering strain E.aerogenes IAM1183-Δ ldhd is better than wild bacterium far away, is to have potentiality hydrogen manufacturing bacterial classification.
Sequence table
<110〉Tsing-Hua University
<120〉a kind of hydrogen production associated protein and encoding gene thereof and application
<130>CGGNARY81498
<160>2
<210>1
<211>329
<212>PRT
<213〉enteroaerogen (E.aerogenes)
<400>1
Met?Lys?Ile?Ala?Val?Tyr?Ser?Thr?Lys?Gln?Tyr?Asp?Lys?Lys?Tyr?Leu
1 5 10 15
Gln?His?Val?Asn?Asp?Thr?Tyr?Gly?Phe?Glu?Leu?Glu?Phe?Phe?Asp?Phe
20 25 30
Leu?Leu?Thr?Glu?Lys?Thr?Ala?Lys?Thr?Ala?Asn?Gly?Cys?Glu?Ala?Val
35 40 45
Cys?Ile?Phe?Val?Asn?Asp?Asp?Gly?Ser?Arg?Pro?Val?Leu?Glu?Glu?Leu
50 55 60
Lys?Ala?Tyr?Gly?Val?Lys?Tyr?Ile?Ala?Leu?Arg?Cys?Ala?Gly?Phe?Asn
65 70 75 80
Asn?Val?Asp?Leu?Asp?Ala?Ala?Lys?Glu?Leu?Gly?Leu?Arg?Val?Val?Arg
85 90 95
Val?Pro?Ala?Tyr?Ser?Pro?Glu?Ala?Val?Ala?Glu?His?Ala?Val?Gly?Met
100 105 110
Met?Met?Ser?Leu?Asn?Arg?Arg?Ile?His?Arg?Ala?Tyr?Gln?Arg?Thr?Arg
115 120 125
Asp?Ala?Asn?Phe?Ser?Leu?Glu?Gly?Leu?Thr?Gly?Phe?Thr?Met?His?Gly
130 135 140
Lys?Thr?Ala?Gly?Val?Ile?Gly?Thr?Gly?Lys?Ile?Gly?Val?Ala?Thr?Leu
145 150 155 160
Arg?Ile?Leu?Lys?Gly?Phe?Gly?Met?Arg?Leu?Leu?Ala?Phe?Asp?Pro?Tyr
165 170 175
Pro?Ser?Ala?Ala?Ala?Leu?Asp?Leu?Gly?Val?Glu?Tyr?Val?Asp?Leu?Pro
180 185 190
Thr?Leu?Tyr?Ala?Gln?Ser?Asp?Val?Ile?Ser?Leu?His?Cys?Pro?Leu?Thr
195 200 205
Glu?Glu?Asn?Tyr?His?Leu?Leu?Asn?His?Ala?Ala?Phe?Glu?Gln?Met?Lys
210 215 220
Asp?Gly?Val?Met?Val?Ile?Asn?Thr?Ser?Arg?Gly?Ala?Leu?Ile?Asp?Ser
225 230 235 240
Gln?Ala?Ala?Ile?Asp?Ala?Leu?Lys?His?Gln?Lys?Ile?Gly?Ala?Leu?Gly
245 250 255
Met?Asp?Val?Tyr?Glu?Asn?Glu?Arg?Asp?Leu?Phe?Phe?Glu?Asp?Lys?Ser
260 265 270
Asn?Asp?Val?Ile?Gln?Asp?Asp?Val?Phe?Arg?Arg?Leu?Ser?Ala?Cys?His
275 280 285
Asn?Val?Leu?Phe?Thr?Gly?His?Gln?Ala?Phe?Leu?Thr?Ala?Glu?Ala?Leu
290 295 300
Ile?Ser?Ile?Ser?Gln?Thr?Thr?Leu?Asp?Asn?Leu?Arg?Gln?Val?Asp?Ala
305 310 315 320
Gly?Glu?Thr?Cys?Pro?Asn?Ala?Ile?Val
325
<210>2
<211>990
<212>DNA
<213〉enteroaerogen (E.aerogenes)
<400>2
atgaaaatcg?ccgtttatag?tacgaagcag?tacgataaaa?agtaccttca?gcatgttaat 60
gatacatatg?gctttgaact?cgaatttttc?gacttcctgt?taaccgaaaa?aaccgcgaaa 120
acggccaacg?gctgtgaagc?cgtgtgcata?tttgtcaacg?atgacggcag?ccgtccggtg 180
ctggaagagc?tgaaagcata?cggggtgaag?tacatcgccc?tgcgctgcgc?cgggtttaac 240
aacgtcgatc?tggatgcggc?aaaagagctg?ggtctgcgcg?ttgtccgcgt?tcccgcctat 300
tcgccggaag?ccgtggctga?acatgccgtc?ggcatgatga?tgtcgttgaa?ccgccgcatc 360
caccgcgctt?accagcgtac?ccgcgatgct?aacttctcgc?tggaaggctt?aaccggcttt 420
accatgcacg?gtaaaaccgc?cggggtgatc?gggaccggca?aaatcggcgt?cgccacgctg 480
cgtattctga?aagggtttgg?catgcgcctg?ctggcgttcg?atccctatcc?aagcgccgca 540
gcgctggatc?tcggcgtcga?gtatgttgat?ttgccgacgc?tgtatgcaca?gtccgatgtg 600
atctccctgc?actgtccgct?gacggaagag?aactaccatc?tgctgaatca?tgcggcgttt 660
gagcaaatga?aagacggcgt?gatggtgatc?aacaccagcc?gcggggcgct?gattgattct 720
caggcggcga?tcgatgcgct?gaaacaccag?aaaatcgggg?cgctgggcat?ggacgtgtat 780
gagaacgaac?gcgacctgtt?cttcgaagat?aagtccaatg?acgtgattca?ggatgacgtc 840
ttccgtcgcc?tgtctgcctg?tcataacgtg?ttgttcaccg?ggcatcaggc?tttcctgacc 900
gccgaagcgc?tgatcagcat?ttcacaaacg?accctggata?acctgcgcca?ggtcgatgct 960
ggcgaaacct?gtccgaacgc?catcgtctaa 990
Claims (14)
1. albumen, the protein of forming by the aminoacid sequence shown in the sequence in the sequence table 1.
2. the described proteic encoding gene of claim 1.
3. gene according to claim 2 is characterized in that: described proteic coding gene sequence is the dna molecular shown in the sequence 2 in the sequence table.
4. contain claim 2 or 3 described expression of gene boxes.
5. the recombinant expression vector that contains claim 2 or 3 described genes.
6. the transgenic cell line that contains claim 2 or 3 described genes.
7. the reorganization bacterium that contains claim 2 or 3 described genes.
8. a hydrogen-producing engineering bacteria is the engineering bacteria that the described gene of claim 2 obtains among the deactivation E.aerogenes IAM1183.
9. engineering bacteria as claimed in claim 8 is characterized in that: described deactivation realizes by homologous recombination.
10. engineering bacteria as claimed in claim 9 is characterized in that: described homologous recombination imports E.aerogenes IAM1183 with suicide carrier pGP704-ldhd and realizes; Described suicide carrier pGP704-ldhd be in the multiple clone site insertion sequence table of pGP704 sequence 2 from 5 ' terminal the 363rd to 898 recombinant vectors that deoxyribonucleotide obtains.
11. suicide carrier pGP704-ldhd, be in the multiple clone site insertion sequence table of pGP704 sequence 2 from 5 ' terminal the 363rd to 898 recombinant vectors that deoxyribonucleotide obtains.
12. contain the transgenic cell line of the described suicide carrier of claim 11.
13. contain the reorganization bacterium of the described suicide carrier of claim 11.
14. the application of arbitrary described engineering bacteria in producing hydrogen in the claim 8 to 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101169755A CN101633691B (en) | 2008-07-22 | 2008-07-22 | Hydrogen production associated protein, coding genes thereof and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101169755A CN101633691B (en) | 2008-07-22 | 2008-07-22 | Hydrogen production associated protein, coding genes thereof and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101633691A CN101633691A (en) | 2010-01-27 |
CN101633691B true CN101633691B (en) | 2011-09-14 |
Family
ID=41593043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101169755A Expired - Fee Related CN101633691B (en) | 2008-07-22 | 2008-07-22 | Hydrogen production associated protein, coding genes thereof and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101633691B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1795270A (en) * | 2003-05-22 | 2006-06-28 | 丰田自动车株式会社 | DNA coding for protein having d-lactic acid dehydrogenase activity and use thereof |
CN1856577A (en) * | 2003-09-30 | 2006-11-01 | 三井化学株式会社 | Biocatalyst for producing d-lactic acid |
-
2008
- 2008-07-22 CN CN2008101169755A patent/CN101633691B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1795270A (en) * | 2003-05-22 | 2006-06-28 | 丰田自动车株式会社 | DNA coding for protein having d-lactic acid dehydrogenase activity and use thereof |
CN1856577A (en) * | 2003-09-30 | 2006-11-01 | 三井化学株式会社 | Biocatalyst for producing d-lactic acid |
Non-Patent Citations (1)
Title |
---|
林海龙.高效产氢菌B49菌株adh和L-ldh基因克隆及序列分析.《微生物学通报》.2008,第35卷(第5期),第788-797页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101633691A (en) | 2010-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Enhanced expression of the codon-optimized exo-inulinase gene from the yeast Meyerozyma guilliermondii in Saccharomyces sp. W0 and bioethanol production from inulin | |
CN110358720B (en) | Zymomonas mobilis recombinant strain for producing isobutanol, construction method and application thereof | |
CN110564710B (en) | Xylanase mutant with high catalytic efficiency and construction method and application thereof | |
CN105647844A (en) | Recombinant bacteria using xylose to produce glycollic acid and building method and application of recombinant bacteria | |
CN101748069B (en) | Recombinant blue-green algae | |
CN104046586A (en) | Genetically engineered bacteria and application of genetically engineered bacteria to production of (2R, 3R)-2,3-butanediol | |
CN111088177B (en) | Construction and application of heat-resistant yeast engineering bacteria for producing glycerol under high-temperature aerobic condition | |
CN102181368B (en) | Technique for biotransforming CO2 into isopropyl alcohol by utilizing blue algae | |
CN101633690B (en) | Hydrogen production associated protein, coding genes thereof and application thereof | |
CN101633691B (en) | Hydrogen production associated protein, coding genes thereof and application thereof | |
CN107201375B (en) | Construction method and application of genetic engineering strain for producing (R, R) -2, 3-butanediol | |
CN114410562A (en) | Klebsiella engineered bacterium and application thereof in ethanol production | |
CN107267559A (en) | A kind of method and its application for improving saccharomyces cerevisiae sucrose fermenting property | |
CN113293121A (en) | Intelligent carbon metabolism flow rate regulation and control method for producing xylitol by using escherichia coli | |
CN104403956B (en) | The structure of xylitol high temperature high-yielding engineering bacterial strain and application | |
CN101423814B (en) | Clostridium for synthesizing glutathion and construction method and use thereof | |
CN110656056B (en) | Construction method of pinene-producing engineering bacteria with high-concentration pinene tolerance | |
CN101423815B (en) | Recombinant acetone-butanol clostridium and construction method and use thereof | |
CN1935991B (en) | Clostridium perfringen glycerol dehydrase gene, and its 1,3-propylene glycol producing method | |
CN111500485B (en) | Clostridium acetobutylicum capable of co-utilizing glucose and xylose and application thereof | |
CN113699081B (en) | Bacillus subtilis for producing (2R, 3R) -butanediol and acetoin through fermentation and application thereof | |
CN109354627B (en) | Method for increasing yield of trehalose hydrolase | |
CN116875521A (en) | Method for knocking out escherichia coli maa gene and lacA gene to improve beta-arbutin yield | |
CN110343653A (en) | A method of it knocking out Escherichia coli aldehyde dehydrogenase gene and improves 1,2,4- butantriol yield | |
KR101815004B1 (en) | Recombinant microorganism using mixed-sugar and method for producing bioethanol using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20120722 |